Device |
system, transdermal delivery, cder or cber led |
Definition |
Drug delivery systems designed to deliver at least one therapeutically active ingredient (drug substance) across the skin for systemic effect. |
Physical State |
Drug delivery systems designed to deliver at least one therapeutically active ingredient (drug substance) across the skin for systemic effect. |
Technical Method |
Drug delivery systems designed to deliver at least one therapeutically active ingredient (drug substance) across the skin for systemic effect. |
Target Area |
Skin. |
Review Panel |
General Hospital |
Product Code | QIX |
Premarket Review |
Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices
(OHT3)
Drug Delivery and General Hospital Devices, and Human Factors
(DHT3C)
|
Not Classified Reason
|
Unknown
|
Submission Type |
Contact ODE
|
Device Class |
Not Classified
|
Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
Implanted Device? |
No
|
Life-Sustain/Support Device? |
No
|
Third Party Review |
Not Third Party Eligible |